Cargando…
Complete and long-lasting response to immunotherapy: A case report of urothelial cancer
INTRODUCTION: Bladder cancer is the tenth most common cancer worldwide, with Europe having the highest incidence rates. Regarding the treatment of metastatic disease, first-line treatment for fit patients is cisplatin-containing combination chemotherapy. However, a significant percentage of patients...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276433/ https://www.ncbi.nlm.nih.gov/pubmed/35713423 http://dx.doi.org/10.1097/MD.0000000000028940 |